| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 07/16/2013 | US8486696 Cell populations which co-express CD49c and CD90 |
| 07/16/2013 | CA2719440C Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of respiratory illness in muscular dystrophy |
| 07/16/2013 | CA2498213C Induction of gene expression using a high concentration sugar mixture |
| 07/16/2013 | CA2486106C Compounds and methods for inhibiting selectin-mediated function |
| 07/16/2013 | CA2483120C Polymeric adhesive transdermal patch comprising rotigotine for treatment of restless leg syndrome |
| 07/16/2013 | CA2358684C Antagonists of tweak and of tweak receptor and their use to treat immunological disorders |
| 07/11/2013 | WO2013102904A1 Methods and compositions for gene delivery |
| 07/11/2013 | WO2013102265A1 Compositions and methods for treating multiple sclerosis |
| 07/11/2013 | US20130177647 Methods for manipulating satiety |
| 07/10/2013 | EP2612917A1 Antisense nucleic acid |
| 07/10/2013 | EP2611437A1 Pharmaceutical composition for prevention and treatment of amyotrophic lateral sclerosis |
| 07/10/2013 | CN103200937A Composition and method for muscle repair and regeneration |
| 07/10/2013 | CN103193860A Tanshinone compounds, preparation method and use thereof |
| 07/10/2013 | CN103193677A Polymorphic form of methocarbamol disodium phosphate and preparation method thereof |
| 07/10/2013 | CN103191302A Use of seven medicinal herbs containing radix polygonati officinalis |
| 07/10/2013 | CN103191286A Traditional Chinese medicine for treating temporomandibular disorders |
| 07/10/2013 | CN103191257A Bone healing tincture |
| 07/10/2013 | CN103191153A Muscular amino acid and nucleoside extract and pharmaceutical composition thereof |
| 07/10/2013 | CN103191127A Anesthetic for deer |
| 07/10/2013 | CN103191059A Neostigmine bromide muhivescular liposome and preparation method thereof |
| 07/09/2013 | US8481504 Insulin-like growth factor (IGF-I) plasmid-mediated supplementation for therapeutic applications |
| 07/09/2013 | US8481489 GH secretagogues and uses thereof |
| 07/09/2013 | US8481091 Pharmaceutical compositions |
| 07/09/2013 | CA2566343C Nutritional composition for increasing creatine uptake in skeletal muscle |
| 07/09/2013 | CA2563739C Bioavailable solid dosage forms of metaxalone |
| 07/09/2013 | CA2527039C Grf analog compositions and their use |
| 07/09/2013 | CA2408408C Modulators of tnf- alpha signaling |
| 07/04/2013 | WO2013101949A2 Composition and method for compounded therapy |
| 07/04/2013 | WO2013100566A1 Phenyl alkyl carbamate derivative compound and pharmaceutical composition containing the same |
| 07/04/2013 | WO2013055385A3 Methods of treating age related disorders |
| 07/04/2013 | US20130172394 Use of pramipexole to treat amyotrophic lateral sclerosis |
| 07/04/2013 | CA2861247A1 Antisense nucleic acids |
| 07/04/2013 | CA2858285A1 1,3-diphenylpropane derivatives, preparations and uses thereof |
| 07/04/2013 | CA2854281A1 A muscle atrophy inhibitor |
| 07/03/2013 | CN103189060A Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound |
| 07/03/2013 | CN103184102A Extraction method and application of agilawood essential oil |
| 07/03/2013 | CN103183660A Chromane derivative used as TRPV3 (transient receptor potential vanilloid 3) conditioning agent |
| 07/03/2013 | CN103183659A Chromane derivative used as TRPV3 (transient receptor potential vanillin 3) regulator |
| 07/03/2013 | CN103183630A Substituted 4-aminocyclohexane derivatives |
| 07/03/2013 | CN103181952A Roxburgh engelhardtia extractive for preventing and treating autoimmune diseases and preparation method thereof |
| 07/02/2013 | US8476286 Quinazoline derivatives which promote the release of parathyroid hormone |
| 07/02/2013 | US8476220 Biocompatible polymers, process for their preparation and compositions containing them |
| 07/02/2013 | CA2504582C Drug delivery device comprising a bilayered polymeric coating having an inhibitor of the mamalian target of rapamycin incorporated into the first polymeric coating layer |
| 06/27/2013 | WO2013092269A1 Pharmaceutical compositions comprising glitazones and nrf2 activators |
| 06/27/2013 | WO2013043580A3 Modified creatine compounds |
| 06/27/2013 | US20130165430 Composition and method for compounded therapy |
| 06/27/2013 | US20130165429 Composition and method for compounded therapy |
| 06/27/2013 | CA2853779A1 Combination therapy with interferon and andrographolides for multiple sclerosis |
| 06/26/2013 | EP2606882A1 Composition for amelioration/prevention of adverse side effect in steroid therapy |
| 06/26/2013 | EP2606066A1 Antibodies that bind myostatin, compositions and methods |
| 06/26/2013 | CN103172631A Condensed pyrimidine derivative serving as transient receptor potential vanilla 3 (TRRV3) regulator |
| 06/26/2013 | CN103169966A Medicinal composition for treating systemic lupus erythematosus |
| 06/26/2013 | CN103169878A Application of gastrodia elata in pharmacy |
| 06/26/2013 | CN103169871A Medicament for treating tic disorder disease |
| 06/26/2013 | CN103169790A Traditional Chinese medicine composition for treating muscle spasm |
| 06/26/2013 | CN103169695A Application of alpha-lipoic acid, acetyl-L-carnitine, coenzyme Q10 and hydroxytyrosol composition for preventing and treating amyotrophy |
| 06/26/2013 | CN103169092A L-asparaginic acid chelated calcium drinking water |
| 06/26/2013 | CN102351934B Steroidal alkaloid compounds and pharmaceutical composition thereof, as well as preparation methods and applications of steroidal alkaloid compounds and pharmaceutical composition of compounds |
| 06/25/2013 | CA2633074C Elongase genes and uses thereof |
| 06/25/2013 | CA2542434C Combination of flupirtine and tolperisone or eperisone for the treatment of painful conditions |
| 06/25/2013 | CA2480217C G-type peptides to ameliorate atherosclerosis |
| 06/20/2013 | WO2013090205A2 Methods for use of neural stem cell compositions for treatment of central nervous system lesions |
| 06/20/2013 | WO2013088084A1 Phytoecdysones for use in improving the muscle quality of obese and/or sarcopenic mammals |
| 06/20/2013 | WO2013045380A3 Pharmaceutically acceptable mglur5 positive allosteric modulators and their methods of identification |
| 06/20/2013 | WO2012034201A3 Creatine-containing food supplement composition, method for preparing same and food supplement dosage form |
| 06/20/2013 | US20130158084 Pharmaceutical Composition Comprising Losartin For Treating or Preventing Statin BasedGrug-Induced Muscle Toxicity |
| 06/19/2013 | EP2604258A1 Pharmaceutical composition comprising Losartan for treating or preventing statin based drug-induced muscle toxicity |
| 06/19/2013 | CN103159788A Condensed imidazole formamide serving as transient receptor potential vanillin 3 (TRPV3) modifier |
| 06/19/2013 | CN103159726A Chromene ketone derivative used as transient receptor potential vanillin3 (TRPV3) antagonist |
| 06/19/2013 | CN103159667A 6-guanidyl-2H-isoindole compound as well as preparation method and application thereof |
| 06/19/2013 | CN103157098A Research for coordinate regulation for microtubule cytoskeleton structure and microfilament cytoskeleton structure and promotion for muscular contraction of UNC-51 kinase |
| 06/19/2013 | CN103157066A Traditional Chinese medicine composition for treating lumbar muscle degeneration |
| 06/19/2013 | CN103157017A Medicine used for treating Parkinsonism |
| 06/19/2013 | CN103157007A Grassleaf sweelflag rhizome and hairyvein agrimony composition medicament |
| 06/19/2013 | CN102367227B Stable Levocarnitine compound and pharmaceutical composition thereof |
| 06/18/2013 | US8466198 Compositions comprising creatine salts and methods of use thereof |
| 06/13/2013 | WO2013085351A1 Pharmaceutical composition comprising diaminodiphenylsulfone or the pharmaceutically acceptable salts thereof for preventing or treating diseases associated with muscle atrophy |
| 06/13/2013 | WO2013085017A1 Pyridone derivative and medicine containing same |
| 06/13/2013 | WO2013085016A1 Pyridone derivative and medicine containing same |
| 06/13/2013 | WO2013082667A1 Use of growth hormone fragments |
| 06/13/2013 | WO2013030569A3 Cell- penetrating peptides having a central hydrophobic domain |
| 06/13/2013 | CA2858576A1 Non-ionic, low osmolar contrast agents for delivery of antisense oligonucleotides and treatment of disease |
| 06/13/2013 | CA2858164A1 Pyridone derivative and medicine containing same |
| 06/13/2013 | CA2857686A1 Use of growth hormone fragments |
| 06/12/2013 | EP2602322A1 Induction of exon skipping in eukaryotic cells |
| 06/12/2013 | EP2601294A1 Antisense oligonucleotide directed removal of proteolytic cleavage sites from proteins |
| 06/12/2013 | EP2601290A2 Somatic stem cells |
| 06/12/2013 | EP2600865A1 Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound |
| 06/12/2013 | CN103154245A Antisense nucleic acid |
| 06/12/2013 | CN103145836A Anti-myostatin single-chain antibody, and its coding gene, expression vector, recombinant transformant and application |
| 06/12/2013 | CN103145738A Imidazo [2,1-b] thiayole derivatives as SIRTUIN modulating compounds |
| 06/12/2013 | CN103145711A Azaadamantane ester and carbamate derivatives and methods of use thereof |
| 06/12/2013 | CN103145706A Imidazopyridine compound with anti-inflammatory action and application thereof to preparation of anti-inflammatory medicament |
| 06/12/2013 | CN103145571A Crystal form of derivative of aminomethyl caproic acid |
| 06/12/2013 | CN103142896A Medicine for treating osteonecrosis of femoral head |
| 06/12/2013 | CN103142764A Traditional Chinese medicine composition for treating soft tissue contusion and preparation method of traditional Chinese medicine composition |
| 06/12/2013 | CN103142753A Chinese medicine composition for treating lumbar muscle strain |
| 06/12/2013 | CN103142604A Acetaminophen and caffeine dispersible tablet, and its preparation method |
| 06/12/2013 | CN103142599A Treatment of T-cell mediated diseases |
| 06/12/2013 | CN103142570A Use of low-dose Ladostigil for neuroprotection |